Navigation Links
Intelsius Introduces Reusable Courier Transit Case
Date:4/23/2013

ORLANDO, Fla., April 23, 2013 /PRNewswire/ -- Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, introduces the first of its kind range of solutions, BioCarrier™, specifically designed for local courier routes and multiple site sample collections. 

(Photo:  http://photos.prnewswire.com/prnh/20130423/DE98247 )
(Logo:  http://photos.prnewswire.com/prnh/20120215/DE53620LOGO )

"Intelsius is proudly introducing the BioCarrier line to the life science leaders and industry professionals at the largest and most well attended clinical trial conference of the year," said David Walsh , CEO, Intelsius.  "This is a regulatory compliant solution rather than couriers carrying samples or medicines from clinic to clinic or pharmacy to pharmacy in picnic coolers."

BioCarrier cases are designed to provide regular route, multiple site sample collection and "home visit" temperature-sensitive injectable drug protection.  The rugged polymer outer with the expanded polypropylene (EPP) insulated liner maintains payload integrity at 2-8 degrees Celsius for 12 hours plus or when using dry ice up to 18 hours.  All three sizes are regulatory compliant with pre-printed UN3373 labels for the shipment of Category B biological samples. 

"The rigid, durable, regulatory compliant marked outer cases feature a clasp closure allowing the lid to be secured and the cases to be stacked and locked together, making them an Intelsius exclusive," said Alex Roskoss, Intelsius European head of technical services.  "These cases were ergonomically designed specifically for couriers to enable safe, comfortable, compliant transportation around the corner or across town," Roskoss added.  Its discreet design keeps the contents confidential. 

"Keeping people safe while samples or medicines are being transported around town is the primary reason for creating the BioCarrier line of products," said Walsh.  Intelsius serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories. 

About Intelsius
Incorporated in 1998, Intelsius is a subsidiary of DGP Life Science Ltd, which is headquartered in York, United Kingdom. With a strong focus on developing environmentally sustainable products and procedures, the company offers solutions to ensure the integrity of customers' products and samples.  Intelsius has a growing global presence with manufacturing facilities, distribution hubs and local offices situated throughout the world, including North America, Europe and Asia. For more information, visit www.intelsius.com.


'/>"/>
SOURCE Intelsius
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intelsius Adds to Highest Performing Products
2. Intelsius Launches Highest Performing Products
3. BioMed Realty Introduces Its 2012 Online Annual Report
4. McCord Animal Health Introduces Board of Advisors
5. Wavien, Inc. Introduces LED Based Medical Illumination Platform Using Recycling Light Technology
6. Olympus Introduces the Worlds Only Articulating HD 3D Laparoscopic Surgical Video System
7. Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
8. Mitek Sports Medicine Introduces New Interference Screw Design For Faster, Easier Insertion
9. Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
10. Endeavor Power Corporation Introduces Its Proprietary FDA Cleared Target System Platform Technology
11. Leviton Introduces Medical-Grade Power Strips for Use in Patient-Care Areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... , May 30, 2016 ... reach USD 7.3 billion by 2024, according to ... The increasing natality rate, the growing malnutrition coupled ... cancer and gastro-intestinal tract diseases are expected to ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ...
(Date:5/30/2016)... LifeScienceIndustryResearch.com adds "Ulcerative Colitis ... with comprehensive information on the therapeutic development for ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Ulcerative Colitis ...
(Date:5/27/2016)... LabStyle Innovations Corp . ( ... today announced that the Company,s Chief Financial Officer, Zvi ... held June 1-2 in New York, NY ... in Los Angeles, CA. ... operational milestones, including the U.S. FDA Clearance and commercial launch ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... ... firm and statement solutions provider, for the tenth consecutive year as a ... issue of Advertising Age, and SourceLink ranked eighteenth in the “U.S. CRM/Direct Marketing ...
(Date:5/31/2016)... ... May 31, 2016 , ... CURE ... patients with cancer, has added Cancer and Careers to its ... timely content on continuing successful careers while fighting cancer. , As partners, both ...
(Date:5/30/2016)... ... ... As the CDC relaxes its stance on traditional No-Nit policies, parents wonder what ... free. , According to a May 26 article from news source KHON2 ... despite the fact that they may be harboring an infestation. Previous No-Nit policies stated ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the leader ... an original infographic, " Health Benefits Reimbursement Compliance Timeline ." , The ... complies with various federal regulations and reforms. , Navigating the new health reforms ...
(Date:5/30/2016)... ... May 30, 2016 , ... Another ER facility operated ... Plano, located at 3960 Legacy Drive, Plano, TX and is open 24 hours daily. ... Commerce followed by a medical open house. The Jasper High School band entertained attendees ...
Breaking Medicine News(10 mins):